Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate Cancer Metastases Are Strongly Inhibited by Agonistic Epha2 Ligands in an Orthotopic Mouse Model
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 10, Pages 2854
Publisher
MDPI AG
Online
2020-10-03
DOI
10.3390/cancers12102854
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
- (2020) Ahmed F. Salem et al. Pharmaceuticals
- EPHB6 mutation induces cell adhesion-mediated paclitaxel resistance via EPHA2 and CDH11 expression
- (2019) Sarah Yoon et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Pharmacological evaluation of new bioavailable small molecules targeting Eph/ephrin interaction
- (2018) Carmine Giorgio et al. BIOCHEMICAL PHARMACOLOGY
- Design and synthesis of small molecule agonists of EphA2 receptor
- (2018) Aaron Petty et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide–Drug Conjugate
- (2018) Ahmed F. Salem et al. JOURNAL OF MEDICINAL CHEMISTRY
- UniPR1331, a small molecule targeting Eph/ephrin interaction, prolongs survival in glioblastoma and potentiates the effect of antiangiogenic therapy in mice
- (2018) Claudio Festuccia et al. Oncotarget
- Structure-Based Design of Novel EphA2 Agonistic Agents with Nanomolar Affinity in Vitro and in Cell
- (2018) Luca Gambini et al. ACS Chemical Biology
- Targeting Eph/ephrin system in cancer therapy
- (2017) Alessio Lodola et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Comprehensive Drug Testing of Patient-derived Conditionally Reprogrammed Cells from Castration-resistant Prostate Cancer
- (2017) Khalid Saeed et al. EUROPEAN UROLOGY
- EphA2 signaling is impacted by carcinoembryonic antigen cell adhesion molecule 1-L expression in colorectal cancer liver metastasis in a cell context-dependent manner
- (2017) Azadeh Arabzadeh et al. Oncotarget
- Novel anti-EPHA2 antibody, DS-8895a for cancer treatment
- (2016) Jun Hasegawa et al. CANCER BIOLOGY & THERAPY
- Truncated EphA2 likely potentiates cell adhesion via integrins as well as infiltration and/or lodgment of a monocyte/macrophage cell line in the red pulp and marginal zone of the mouse spleen, where ephrin-A1 is prominently expressed in the vasculature
- (2016) Naoko Konda et al. HISTOCHEMISTRY AND CELL BIOLOGY
- Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial
- (2016) Nicholas D James et al. LANCET
- Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
- (2016) Himisha Beltran et al. NATURE MEDICINE
- Improving Taxane-Based Chemotherapy in Castration-Resistant Prostate Cancer
- (2016) Jan Kroon et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Therapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine
- (2016) Bridget A. Quinn et al. Oncotarget
- Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells
- (2015) Bainan Wu et al. CHEMISTRY & BIOLOGY
- Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
- (2015) Christopher J. Sweeney et al. NEW ENGLAND JOURNAL OF MEDICINE
- EphA2 promotes cell adhesion and spreading of monocyte and monocyte/macrophage cell lines on integrin ligand-coated surfaces
- (2015) Noritaka Saeki et al. Cell Adhesion & Migration
- Design, Synthesis and Bioevaluation of an EphA2 Receptor-Based Targeted Delivery System
- (2014) Elisa Barile et al. ChemMedChem
- EphA2 enhances the proliferation and invasion ability of LNCaP prostate cancer cells
- (2014) PEIJIE CHEN et al. Oncology Letters
- Target Hopping as a Useful Tool for the Identification of Novel EphA2 Protein-Protein Antagonists
- (2013) Massimiliano Tognolini et al. ChemMedChem
- Amino Acid Conjugates of Lithocholic Acid As Antagonists of the EphA2 Receptor
- (2013) Matteo Incerti et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Structure-Activity Relationships of Amino Acid Conjugates of Cholanic Acid as Antagonists of the EphA2 Receptor
- (2013) Simonetta Russo et al. MOLECULES
- Targeted Delivery of Paclitaxel to EphA2-Expressing Cancer Cells
- (2012) S. Wang et al. CLINICAL CANCER RESEARCH
- Novel Targeted System To Deliver Chemotherapeutic Drugs to EphA2-Expressing Cancer Cells
- (2012) Si Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Small Molecule Agonist of EphA2 Receptor Tyrosine Kinase Inhibits Tumor Cell Migration In Vitro and Prostate Cancer Metastasis In Vivo
- (2012) Aaron Petty et al. PLoS One
- Structure−Activity Relationship Analysis of Peptides Targeting the EphA2 Receptor
- (2010) Sayantan Mitra et al. BIOCHEMISTRY
- Emerging strategies for EphA2 receptor targeting for cancer therapeutics
- (2010) Manish Tandon et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Anti-EphA2 Antibodies with Distinct In Vitro Properties Have Equal In Vivo Efficacy in Pancreatic Cancer
- (2010) Helenia Ansuini et al. Journal of Oncology
- Cell adhesion and EGFR activation regulate EphA2 expression in cancer
- (2009) Alice Bjerregaard Larsen et al. CELLULAR SIGNALLING
- Eph-Ephrin Bidirectional Signaling in Physiology and Disease
- (2008) Elena B. Pasquale CELL
- Over-Expression of EphA2 and EphrinA-1 in Human Gastric Adenocarcinoma and Its Prognostic Value for Postoperative Patients
- (2008) Wei-Jie Yuan et al. DIGESTIVE DISEASES AND SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now